Please ensure Javascript is enabled for purposes of website accessibility

Down 19.7%, Is CannTrust Holdings Stock Now a Bargain?

By George Budwell – Updated Apr 17, 2019 at 12:40PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market wasn't kind to this Canadian pot stock last week, but a rebound could be imminent.

Last week, Canadian pot company CannTrust Holdings (CNTTQ -13.33%) lost nearly 20% of its value after reporting fourth-quarter earnings on Thursday. The fly in the ointment, so to speak, was the company's disappointing revenue haul of CA$16.2 million (roughly $12.1 million at current exchange rates) over the course of Q4, and the fact that the company's net loss of CA$0.26 per share far exceeded Wall Street's consensus estimate for the three-month period of CA$0.04 per share. 

Did investors overreact to this underwhelming earnings report? Let's look at CannTrust's prospects to find out. 

A stand of cannabis plants growing outdoors.

Image Source: Getty Images.

Can CannTrust stand out from the crowd? 

Like most pot companies not named Aurora Cannabis, Canopy Growth, or Cronos Group, CannTrust is in a bit a of bind. With no major partner to help with its expansion process, and a middle-of-the-pack production output of around 100,000 kg per year mainly through its hydroponic facilities, CannTrust doesn't exactly have any major differentiating factors to attract investors.

Yes, the company does have a healthy footprint in the medical cannabis space, but that simply won't be enough to survive the eventual oversupply of the Canadian cannabis market -- when dried flower prices are expected to plummet. 

However, CannTrust did give its shareholders and potential investors a ray of hope during its latest quarterly earnings update. According to the report, CannTrust has entered into letters of intent to secure an additional 200 acres of land slated for a massive outdoor grow facility.

The company suggested that this new acreage could boost its annual peak output by 100,000 to 200,000 kg per year as soon as 2020. A total peak annual output of 200,000 kg would put CannTrust into the top six Canadian producers overall; a 300,000 kg annual haul, on the other hand, would catapult the company solidly into third place -- behind only Aurora and Canopy Growth in terms of peak cultivation capacity.

Apart from this dramatic increase in production capacity, CannTrust should also benefit from the tremendous cost-savings that comes with outdoor grows, compared to greenhouse or indoor-grown cannabis.

According to industry insiders, outdoor cannabis can be grown and harvested at between 20% to 25% of the cost of greenhouse and indoor crops. In a space where gross margins are expected to nosedive within the next 18 months, this enormous cost-savings should prove to be a significant competitive advantage.    

Check out the latest earnings call transcripts for the companies we cover.

Is CannTrust a bargain?

At right around eight times forward-looking sales, CannTrust's shares are decidedly cheaper than Aurora, Canopy, or Cronos at these levels. Plus, the company's decision to jump into the outdoor growth game could provide significant cost-savings and help lower the impact of falling profit margins across the industry in the next year or so.

Best of all, CannTrust's last stated position of CA$72 million in cash and short-term investments should be sufficient to complete the company's ongoing expansion. After all, this pot company could return to profitability before year's end. CannTrust, in turn, shouldn't need to dilute current shareholders into the abyss to complete this rapid buildout, although the company's outstanding share count should rise modestly over the next two years following the company's move to the New York Stock Exchange last month and follow-on shelf prospectus worth up to CA$700 million ($522 million) in mid-March.   

All things considered, CannTrust's nosedive last week seems like a gift for patient investors. CannTrust doesn't sport an outrageous valuation after this recent pullback, and the company also hasn't been a dilution machine like some of its peers with far richer valuations -- at least not yet. Moreover, CannTrust's outdoor growth strategy could put it into the upper tier of Canadian growers within the next year and a half. So, if you're searching for a pot stock with a reasonable valuation and a solid outlook, CannTrust is definitely worth a look right now.


George Budwell has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CannTrust Holdings Inc. Stock Quote
CannTrust Holdings Inc.
$0.00 (-13.33%) $0.00
Canopy Growth Stock Quote
Canopy Growth
$2.86 (4.38%) $0.12
Cronos Group Stock Quote
Cronos Group
$2.90 (2.47%) $0.07
Aurora Cannabis Stock Quote
Aurora Cannabis
$1.21 (4.31%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.